Whole body hyperthermia: a potent radioprotector in vivo

Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):525-30. doi: 10.1016/0360-3016(91)90065-c.

Abstract

Interleukin-1 has been reported to be an effective radioprotective agent in mice subjected to lethal doses of irradiation. Production of Interleukin-1 can be increased by whole body hyperthermia. Therefore, whole body hyperthermia was assessed for its efficacy in protecting the lethal effects of ionizing radiation in DBA/2 mice. One hour of 40 degrees C +/- 0.2 whole body hyperthermia given 20 hr before 900 cGy total body irradiation protected 100% of DBA/2 mice from an LD 100/16 radiation dose (dose of irradiation that killed 100% of the mice in 16 days). Lethal doses of total body irradiation produced profound monocytopenia, decreased cellularity of thymus, spleen, and bone marrow, and suppressed Interleukin-1 production. Interleukin-1 production was determined using the thymocyte proliferation assay. Whole body hyperthermia accelerated recovery of blood leukocytes by up to 5 days post-total body irradiation in DBA/2 mice. Thymocytes, spleen, and bone marrow cells were activated by whole body hyperthermia, as assessed by the cell's response to Concanavalin A. This was accompanied by accelerated Interleukin-1 generation. Our results provide the first evidence that whole body hyperthermia acts as a potent radioprotector in vivo, effects that may be mediated by Interleukin-1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Bone Marrow / drug effects
  • Bone Marrow / radiation effects
  • Female
  • Hyperthermia, Induced / methods*
  • Interleukin-1 / biosynthesis
  • Leukocyte Count / radiation effects
  • Lymphocyte Activation / radiation effects
  • Lymphocytes / metabolism
  • Mice
  • Mice, Inbred DBA
  • Radiation Dosage
  • Radiation Protection
  • Whole-Body Irradiation / adverse effects*
  • Whole-Body Irradiation / mortality

Substances

  • Interleukin-1